Alex Mattia, DPM
Foot & Ankle Surgery · Washington, DCNPI 1780117051
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.8%), education and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Arthrex at 44.4% of the total. Reporting peaked in 2021 at $7,108 and has fallen 81.5% since, to $1,316 in 2025.
Across 90 payments — averaging $147.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$6K
- Supreme Orthopedic Systems, LLC$3K
- Stryker$2K
- Paragon 28, Inc.$2K
- Johnson & Johnson$462
- Convatec Inc.$284
- plus $415 from 7 others
What the payments were for
- Travel & lodging$5,94845%
- Food & beverage$3,27725%
- Education$4,06431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 38 | $5,906 |
| Supreme Orthopedic Systems, LLC | 13 | $2,982 |
| Stryker | 16 | $1,639 |
| Paragon 28, Inc. | 4 | $1,600 |
| Johnson & Johnson | 3 | $462 |
| Convatec Inc. | 3 | $284 |
| Atricure, Inc. | 1 | $123 |
| Smith+Nephew | 6 | $98 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $90 |
| Integra Lifesciences Corporation | 2 | $53 |
| Hartmann USA, Inc. | 1 | $21 |
| Mimedx Group, Inc. | 1 | $15 |
| Organogenesis Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRIME SERIES$1,150
- Product Portfolio$1,097
- DPM COURSE$432
- MOTOBAND$388
- InnovaMatrix AC$269
- DISTAL EXTREMITIES IMPLANTS SOFT TISSUE ANCHORS$124
- EPI-SENSE GUIDED COAGULATION SYS$123
How this compares
$13,289 in reported general payments places this provider in the 65th percentile of 23 foot & ankle surgery providers in District of Columbia.
See all foot & ankle surgery providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 1,451 | $31,251 |
| Ammonium Lactate | 551 | $9,637 |
| Diclofenac Sodium | 84 | $2,712 |
| Clotrimazole | 95 | $1,466 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 20 | $549 |
| Silver Sulfadiazine | 21 | $255 |
| Ibuprofen | 19 | $251 |
| SsdSilver Sulfadiazine | 12 | $156 |
| Oxycodone Hcl | 24 | $119 |
| Pregabalin | 11 | $101 |
| Methylprednisolone | 11 | $97 |
| Meloxicam | 15 | $30 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Washington
- Paul CooperWashington$186K
- John SteinbergWashington$166K
- Ali Rahnama VaghefWashington$132K
- Jayson AtvesWashington$24K
- Shelton McKenzieWashington$22K
- Bilal LouzatiWashington$18K
- Ali QadriWashington$17K
- Emily DurranceWashington$9K
- Selin RuggieriWashington$7K
- Caitlin ZarickWashington$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.